Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size

Therapeutic Variables in Cataract Surgery

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00407017
First received: November 30, 2006
Last updated: August 17, 2007
Last verified: August 2007
History of Changes
  Purpose

The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.


Condition Intervention Phase
Cataract Surgery
 Drug: Gatifloxacin
Drug: Ketorolac LS
Drug: Pred Forte
Drug: Moxifloxacin
Drug: Nepafenac
Drug: EconoPred Plus
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind

Resource links provided by NLM:

MedlinePlus related topics: Cataract
U.S. FDA Resources

Further study details as provided by Innovative Medical:
  Eligibility
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Males or females scheduled to undergo cataract surgery
  • Patients can be receiving monofocal IOLs only
  • Likely to complete all study visits and able to provide informed consent
  • Visual potential of 20/25 or better

Exclusion Criteria:

  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease
  • Active ocular allergies
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00407017

Locations
United States, Florida
The Center for Excellence in Eye Care
Miami, Florida, United States, 33176
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: William Trattler, MD The Center For Excellence in Eye Care
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00407017     History of Changes
Other Study ID Numbers: 5264-T
Study First Received: November 30, 2006
Last Updated: August 17, 2007
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on March 03, 2015